Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Amplicon contamination in labs masquerades as COVID19 in surveillance tests

Dan Davidi, Susan Fitzgerald, Hannah L. Glaspell, Samantha Jalbert, Stylianos Maheras, Stephanie E. Mattoon, Vanessa M. Britto, Davidson H. Hamer, Giang T. Nguyen, Judy Platt, Cecilia W. Stuopis, Joshua E. Turse, Michael Springer
doi: https://doi.org/10.1101/2020.12.08.20244525
Dan Davidi
1Department of Genetics, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Fitzgerald
2Harvard University Health Services, Harvard University, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah L. Glaspell
3Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Jalbert
4Department of Systems Biology, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stylianos Maheras
2Harvard University Health Services, Harvard University, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie E. Mattoon
3Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa M. Britto
5Department of Medicine/ University Health Services, Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davidson H. Hamer
6Department of Global Health, Boston University School of Public Health, Boston, MA, USA
7Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
8National Emerging Infectious Diseases Laboratory, Boston University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giang T. Nguyen
2Harvard University Health Services, Harvard University, Cambridge, MA, USA
9Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judy Platt
10Student Health Services, Boston University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia W. Stuopis
11MIT Medical, Massachusetts Institute of Technology, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua E. Turse
3Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Springer
4Department of Systems Biology, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael_springer@hms.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

A cohort of laboratorians with positive SARS-CoV2 test results were uncovered during asymptomatic COVID-19 screening programs at six universities. Follow-up PCR and antibody tests showed that most of these cases were not true COVID-19 infection but instead arose from reverse-transcribed and amplified viral sequences (amplicons) that are generated during research. Environmental testing showed widespread contamination of amplicons in lab spaces including notebooks, keyboards, glasses, and doorknobs. Minimizing instances of amplicon contamination and developing protocols for handling suspected cases are critical to propel research efforts and to avoid diverting university and healthcare resources from patients with COVID-19. Removal of these individuals from the standard testing protocol, per CDC guidelines for positive cases, risks the spread of true infection. We discuss potential prevention and mitigation strategies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

no external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Improving Point-of-Care Diagnostics for COVID-19 IRB20-0581 The Institutional Review Board (IRB) of the Harvard Faculty of Medicine approved this Initial Study

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all data presented in this paper is available on submission as a supporting excel file

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Amplicon contamination in labs masquerades as COVID19 in surveillance tests
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Amplicon contamination in labs masquerades as COVID19 in surveillance tests
Dan Davidi, Susan Fitzgerald, Hannah L. Glaspell, Samantha Jalbert, Stylianos Maheras, Stephanie E. Mattoon, Vanessa M. Britto, Davidson H. Hamer, Giang T. Nguyen, Judy Platt, Cecilia W. Stuopis, Joshua E. Turse, Michael Springer
medRxiv 2020.12.08.20244525; doi: https://doi.org/10.1101/2020.12.08.20244525
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Amplicon contamination in labs masquerades as COVID19 in surveillance tests
Dan Davidi, Susan Fitzgerald, Hannah L. Glaspell, Samantha Jalbert, Stylianos Maheras, Stephanie E. Mattoon, Vanessa M. Britto, Davidson H. Hamer, Giang T. Nguyen, Judy Platt, Cecilia W. Stuopis, Joshua E. Turse, Michael Springer
medRxiv 2020.12.08.20244525; doi: https://doi.org/10.1101/2020.12.08.20244525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)